Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kirsten F. L. Douma"'
Publikováno v:
Familial cancer, 15(2), 231-240. Springer Netherlands
Familial Cancer
Familial Cancer
This study aimed to gain insight into the gatekeeper role of surgeons and gastroenterologists (including residents) during a first consultation at a tertiary gastro-intestinal centre regarding referral for genetic counselling, and to test the feasibi
Autor:
Mariana S. Sousa, Katherine L. Tucker, Judy Kirk, Christobel Saunders, Gillian Mitchell, Belinda Rahman, Kristine Barlow-Stewart, Margaret Gleeson, Kirsten F. L. Douma, Bettina Meiser
Publikováno v:
Familial cancer, 14(2), 265-272. Springer Netherlands
Increasingly, women are offered genetic testing shortly after diagnosis of breast cancer to facilitate decision-making about treatment, often referred to as 'treatment-focused genetic testing' (TFGT). As understanding the attitudes of health professi
Publikováno v:
Colorectal Cancer, 2(1), 13-16. Future Medicine Ltd.
Gastroenterologists play a key role in the life-long medical care (surveillance and treatment) of individuals at high risk for developing colorectal cancer (CRC) owing to a genetic disposition. Therefore, to what extent should gastroenterologists be
Autor:
Linda C. Zandbelt, Caro C.E. Koning, Lukas J.A. Stalpers, Kirsten F. L. Douma, Ellen M. A. Smets, Hanneke C. J. M. de Haes
Publikováno v:
Acta oncologica (Stockholm, Sweden), 51(4), 512-520. Informa Healthcare
Background. Our study aims to investigate whether information given by radiation oncologists to their patients is tailored to the patient's desired level of information and, if so, what the effect of tailoring is on patient-reported outcomes, i.e. sa
Autor:
Kirsten F. L. Douma, Neil K. Aaronson, Hans F. A. Vasen, Chad M. Gundy, Eveline M. A. Bleiker, Miranda A. Gerritsma
Publikováno v:
Psycho-Oncology. 20:146-154
Objective: Familial adenomatous polyposis (FAP) is a genetic condition characterized by the development of multiple adenomas in the colorectum that could lead to colorectal cancer. Our aim was to assess levels and predictors of psychological distress
Autor:
Annemieke Cats, Chad M. Gundy, Hans F. A. Vasen, Miranda A. Gerritsma, E. M. A. Bleiker, Kirsten F. L. Douma, Neil K. Aaronson
Publikováno v:
Colorectal Disease. 12:1198-1207
Aim The study assessed compliance of patients with familial adenomatous polyposis (FAP) with endoscopic surveillance. Method In this nationwide, cross-sectional study, individuals from FAP families registered with the Netherlands Foundation for the D
Autor:
Eveline M. A. Bleiker, Neil K. Aaronson, Kirsten F. L. Douma, Chad M. Gundy, Hans F. A. Vasen
Publikováno v:
Colorectal Disease. 13:669-677
The study aimed to document the impact of familial adenomatous polyposis (FAP) on health-related quality of life (HRQOL) and several practical aspects of daily life, and to identify factors significantly associated with HRQOL. This study is the first
Autor:
Frank E. Bellot, Frits S.A.M. van Dam, Wim H. van Harten, Rudi M. H. Roumen, Valesca P. Retèl, J. Marjan Hummel, Cees van Krimpen, Jolien M. Bueno-de-Mesquita, Kirsten F. L. Douma, Marc J. van de Vijver, Sabine C. Linn, Kim Karsenberg
Publikováno v:
International journal of technology assessment in health care, 25(1), 73-83. Cambridge University Press
Objectives:Constructive Technology Assessment (CTA) is a means to guide early implementation of new developments in society, and can be used as an evaluation tool for Coverage with Evidence Development (CED). We used CTA for the introduction of a new
Publikováno v:
Psycho-oncology. 17(8):737-745
Objectives: Familial adenomatous polyposis (FAP) is characterized by the development of multiple adenomas in the colon that can lead to colorectal cancer. Being a carrier for FAP is hypothesized to have a negative impact on psychosocial well-being. T
Autor:
Kirsten F. L. Douma, Wim H. van Harten, J. Marjan Hummel, Kim Karsenberg, Jolien M. Bueno-de-Mesquita
Publikováno v:
International journal of technology assessment in health care, 23(2), 162-168. Cambridge University Press
Objectives: Technologies in health care are evolving quickly, with new findings in the area of biotechnological and genetic research being published regularly. A health technology assessment (HTA) is often used to answer the question of whether the n